- About Us
- Pharmalicensing - Open Innovation for the life sciences
- Our Products
- Overview
- Partnering Search
- Company Profiling
- PL Intelligence
- Reports
- Partnering Consulting
- Due Diligence
- Comparison
- PL Intelligence
- Overview
- Industry news
- Deals review
- Press releases
- Articles
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Due Diligence
- Overview
- Top Applications
- Online Panel Discussions
- Request Consultation
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire
- Jobs
- Forums
- Contact Pharmalicensing
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
is a division of
- Deals review
- Deal details
Immune Response initiates phase I trial of brain tumour vaccine
In order to access this content you must be logged in and have a subscription to PL Intelligence.
PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Related deals
Nexell Therapeutics initiates program to develop tumour cell test
Immune Response licenses Hybridon's 2nd-generation CpG DNA adjuvant
ImmunoVaccine Technologies Broadens Its Patent Protection to Japan
Immune Response to pursue development of preventive HIV vaccine
Neurocrine presents malignant brain tumour treatment data
Immune Response receives two U.S. patents
Aventis and Medigene sign strategic alliance for tumour vaccine
Immune Response announces restructuring of license agreement
Related categories
- Therapeutic target
- Immune related disorders
- Oncology
- Industry sector
- Pharmaceutical
More deals
Latest deals
- Antitope Ltd and Vascular Pharmaceuticals Enter into a Antibody Research Agreement
- Bayer Schering Pharma Extends Research Portfolio in the Field of Cancer-Related Targets
- Bayer CropScience and Monsanto sign cross licensing agreement on herbicide tolerance traits in rapeseed/canola
- GVK Biosciences announces Agreement With University of Tokyo on GPCR Database
- Wockhardt signs agreement to divest its Animal Health Division
Most viewed deals
- Bayer CropScience and Janssen PMP conclude research agreement:
- Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded to Singapore and Vietnam
- Bayer CropScience and Evogene to extend collaboration for rice yield improvement
- Galapagos and Opsona Therapeutics initiate drug discovery collaboration
- Merck & Co., Inc., Medarex, Inc. and Massachusetts Biologic Laboratories Sign Exclusive Licensing Agreement for Investigational Monoclonal Antibody Combination for Clostridium Difficile Infection
© Copyright 1995-2009 Pharmalicensing, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us